KMT2A and leukemia: These methods were either the knock-in model, which involved fusing the MLL gene partner AF9 into the mouse Mll gene, resulting in acute myeloid leukaemias in mice [30,31], or the translocator model [32,33] to give de novo chromosomal translocations, resulting in cell-specific leukaemias [34].